Placeholder Banner

BIO and Croplife International Submit Amicus Brief in Impression Products Inc. v. Lexmark International Inc. (U.S. Supreme Court)

February 23, 2017

BIO and CropLife International submitted an amicus brief in Impression Products, Inc. v. Lexmark International, Inc., at the Supreme Court of the United States.

BIO and CropLife members have a substantial interest in the patent exhaustion questions before the Court in this case. BIO and CropLife members have relied on longstanding patent exhaustion doctrine to structure their businesses – from investment in research and development to sales of their products and ultimately to their investment in future innovation. BIO and CropLife members have long relied on the doctrines to plan their research and development efforts, determine market prices of their patented products, negotiate sales of those products, and reinvest for further innovation. Given the importance of these doctrines and the public policy considerations underlying them, BIO and CropLife ask the Supreme Court to affirm the holding.

Related Resources
Lexmark BIO Supreme Court Brief
BIO and Croplife International Submit Brief of Amicus Curiae in Impression Products Inc. v. Lexmark International Inc. (Supreme Court of the United States)
Discover More
The Biotechnology Innovation Organization (BIO) today signed onto an amicus brief to challenge the Federal Trade Commission (FTC) lawsuit to block the acquisition of Horizon by Amgen. The amicus brief was filed in the U.S. District Court, Northern…
BIO has filed an amicus brief in U.S. ex rel. Scutte v. SuperValu Inc., which addresses the issue of the intent requirement under the False Claims Act (FCA). Specifically, BIO urges the Court to uphold the view that a firm does not…
The Biotechnology Innovation Organization (BIO) today signed onto an amicus brief to challenge a District Court’s unprecedented ruling (related to a single drug known as mifepristone) that would create regulatory barriers and potentially upend FDA’s…